Skip to main content
. Author manuscript; available in PMC: 2017 Jan 4.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):313–322. doi: 10.1097/QAI.0000000000001093

Figure 1.

Figure 1

Descriptive statistics for IPV exposure during the study. A) Type of IPV reported at each study visit in which any IPV was reported. B) Number of IPV episodes reported since the last study visit. Data were not collected on frequency of economic IPV. C) Reported consequences of IPV. Consequences marked with an asterisk (*) were explicitly listed as response options, while those without the asterisk were described by participants in the open-ended “other” category. Note: participants were only asked to describe IPV consequences during follow-up visits. Data are missing for the IPV episodes reported at enrollment